Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India

Indian Journal of Pathology and Microbiology

Volumn 56, Issue 4, 2013, Pages 378-383

  Makroo, Raj Nath ^a   Arora, Jatinder Singh ^a   Chowdhry, Mohit ^a   Bhatia, Aakanksha ^a   Thakur, Uday Kumar ^a   Minimol, Antony ^a  

^a INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

Alloimmunization; infectious marker; thalassemia

Indexed keywords

ADOLESCENT; ADULT; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; INDIA; INFANT; MALE; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; THALASSEMIA; YOUNG ADULT;

EID: 84893912667     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.125295     Document Type: Article

References (30)

1. Singer ST, Wu V, Mignacca R, Kuypers FA, More lP, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusiondependent thalassemia patients of predominantly Asian descent. Blood 2000;96:3369-73.
2. Dhot PS. Amendments to Indian drugs and cosmetics act and rules pertaining to blood banks in armed forces. Med J Armed Forces India 2005;61:264-6.
3. Choudhry VP, Acharya SK. Hepatitis B, C & D viral markers in multitransfused thalassemic children: Long-Term complications and present management. Indian J Pediatr 1995;62:655-68.
4. Joshua DJ, Krishnamoorthy R, Muddegowda PH, Subash S, Lingegowda JB. Red cell alloimmunization and transfusion transmitted infections in repeatedly transfused thalassemia major patients. Int J Curr Sci Res 2012; 2: 251-4.
5. Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology 2010;15:174-7.
6. Gupta R, Singh DK, Singh B, Rusia U. Alloimmunization to red cells in thalassemics: Emerging problem and future strategies. Transfus Apher Sci 2011;45:167-70.
7. Saied DA, Kaddah AM, Badr Eldin RM, Mohaseb SS. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients. J Pediatr Hematol Oncol 2011;33:409-14.
8. el Danasoury AS, Eissa DG, Abdo RM, Elalfy MS. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion 2012;52:43-7.
9. Noor Haslina MN, Ariffin N, Illuni Hayati I, Rosline H. Red cell immunization in multiply transfused Malay thalassemic patients. Southeast Asian J Trop Med Public Health 2006;37:1015-20.
10. Wang LY, Liang DC, Liu HC, Chang FC, Wang CL, Chan YS, et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 2006;16:200-3.
11. Sadeghian MH, Keramati MR, Badiei Z, Ravarian M, Ayatollahi H, Rafatpanah H, et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Transfus Sci 2009;3:95-8.
12. Ameen R, Al-Shemmari S, Al-Humood S, Chowdhury RI, Al-Eyaadi O, Al-Bashir A. RBC alloimmunization and autoimmunization among transfusiondependent Arab thalassemia patients. Transfusion 2003;43:1604-10.
13. Bilwani F, Kakepoto GN, Adil SN, Usman M, Hassan F, Khurshid M. Frequency of irregular red cell alloantibodies in patients with thalassemia major: A bicenter study. J Pak Med Assoc 2005;55:563-5.
14. Michail-Merianou V, Pamphili-Panousopoulou L, Piperi-Lowes L, Pelegrinis E, Karaklis A. Alloimmunization to red cell antigens in thalassemia: Comparative study of usual versus better-match transfusion programmes. VoxSang1987;52:95-8.
15. Makroo RN, Bhatia A, Gupta R, Phillip J. Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population. Indian J Med Res 2013;137:521-6.
16. Thakral B, Saluja K, Sharma RR, Marwaha N. Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donors. Transfus Apher Sci 2010;43:17-22.
17. Younus M, Hassan K, Ikram N, Naseem L, Zaheer HA, Khan MF. Hepatitis C virus seropositivity in repeatedly transfused thalassemia major patients. Int J Pathol 2004;2:20-3.
18. Tulsiani S, Choudhury N, Desai P, Shah R, Mathur A, Harimoorthy V, et al. True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India. Asian J Transfus Sci 2012;6:165-8.
19. Tucker TJ, Voigt M, Bird A, RobsonS, GibbsB, Kannemeyer J, et al. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape-Comparison of screening tests and PCR. S Afr Med J 1997;87:603-5.
20. Mollah AH, Nahar N, Siddique MA, Anwar KS, Hassan T, Azam MG. Common transfusion-Transmitted infectious agents among thalassaemic children in Bangladesh. J Health Popul Nutr 2003;21:67-71.
21. Al-Sheyyab M, Batieha A, El-Khateeb M. The prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers in multitransfused patients. J Trop Pediatr 2001;47:239-42.
22. Williams TN, Wonke B, Donohue SM. A study of hepatitis B and C prevalence and liver function in multiply transfused thalassemic and their parents. Indian Pediatr 1992;29:1119-24.
23. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat 2002;9:390-2.
24. Irshad M, Peter S. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J Gastroenterol 2002;21:183-4.
25. Agarwal MB, Malkan GH, Bhave AA, Vishwanathan C, Billa V, Dube SR, et al. Antibody to hepatitis-C virus in multi-Transfused thalassaemics-Indian experience. J Assoc Physicians India 1993;41:195-7.
26. Wonke B, Hoffbrand AV, Brown D, Dusheiko G. Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. J Clin Pathol 1990;43:638-40.
27. Karimi M, Ghavinini AA. Seroprevalence of hepatitis B, hepatitis C and HIV antibodies among multi-Transfused thalassemia children in Shiraz. Iran J Pediatr Child Health 2001;37:564-6.
28. Angelucci E. Antibodies to hepatitis C virus in thalassemia. Haematologica 1994;79:353-5.
29. Rehman M, Lodhi Y. Prospects of future of conservative management of β-Thalassemia major in a developing country. Pak J Med Sci 2004;20:105-7.
30. Makroo RN, Choudhury N, Jagannathan L, Parihar-Malhotra M, RainaV, Chaudhary RK, et al. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 & hepatitis B & C viruses in Indian blood donors. Indian J Med Res 2008;127:140-7.